Our data also demonstrated that the expression of pro-inflammatory neutrophils and CRP was significantly increased in cancer patients with COVID-19, and further through multivariate regression analysis showed that they can be used as independent predictors of the severity and the clinical adverse outcome of COVID-19. This evidence concerns the gene CRP and cancer.